LICOFLIGOZIN POUR LE TRAITEMENT DE LA STÉATOHÉPATITE NON ALCOOLIQUE
- 专利权人:
- Novartis AG
- 发明人:
- 申请号：
- EP18746749.3
- 公开号：
- EP3641755A1
- 申请日:
- 2018.06.20
- 申请国别(地区):
- EP
- 年份:
- 2020
- 代理人:
- 摘要：
- The disclosure concerns the use of LIK066 in the treatment, prevention or delay of non-alcoholic steatohepatitis.L'invention concerne l'utilisation de LIK066 dans le traitement, la prévention ou le retardement de la stéatohépatite non alcoolique.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- LICOFLIGOZIN POUR LE TRAITEMENT DE LA STÉATOHÉPATITE NON ALCOOLIQUE
- USE OF (4-HYDROXY-2-METHYL-1,1-DIOXIDO-2H-BENZO[E][1,2]THIAZINE-3-YL)(NAPHTHALENE-2-YL) METHANONE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
- USE OF (4-HYDROXY-2-METHYL-1,1-DIOXIDO-2H-BENZO[E][1,2]THIAZINE-3-YL)(NAPHTHALENE-2-YL) METHANONE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
- METHOD OF TREATING NONALCOHOLIC STEATOHEPATITIS WITH ELEVATED DOSES OF URSODEOXYCHOLIC ACID
- VERWENDUNG VON (4-HYDROXY-2-METHYL-1,1-DIOXIDO-2H-BENZO[E] [1,2] THIAZIN-3-YL)(NAPHTHALEN-2-YL)METHANON ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON NICHTALKOHOLISCHER STEATOHEPATITIS
